FDA May Revoke Immucor's Blood Reagent License


The Food and Drug Administration issued Immucor Inc. (Nasdaq: BLUD) a notice of intent to revoke the license for some blood reagents sending the stock price plunging $2.77 to $13.32.

About this Entry

This page contains a single entry by published on June 26, 2009 8:40 AM.

Palm Beats Estimates was the previous entry in this blog.

KB Home Disappoints is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12